Project Grant HT94252510223
Award Date
4/1/25
Completion Date
3/31/28
Dollars Obligated
$1M
Federal Agency
Defense Health Agency
Awardee
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. (UYLKBRENAPG5)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Westlake, MD 20817, USA
Similar Awards
This $2,402,721.00 Project Grant was awarded on April 15, 2025 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. The grant funds the development of a patient monitoring and decision-support platform for precision health, with an ultimate completion date of April 14, 2027. The Henry M. Jackson Foundation, a global non-profit organization, will leverage its...
This federal Project Grant award, valued at $319,151.00, was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant supports research conducted by The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) on a novel miR-155 therapy for the treatment of peripheral neuropathy. The project aims to develop new treatments, diagnostic tools, and clinical practice guidelines to improve the health and...
The Defense Health Agency awarded a $478,061 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). This grant, with a performance period from September 1, 2024 to August 31, 2026, supports the development of an organoid model for ovarian cancer research and precision medicine. The Henry M. Jackson Foundation, a global non-profit organization, will use this funding to advance...
This Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $1,898,000.00 to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. to develop a rapid, fieldable nanopore sequencing-based prognostic and diagnostic assay. The goal is to advance clinical management decision-making for the military medical community. The award has a performance period from September 30, 2024 to September 29, 2027. The...
The Department of Defense's Defense Health Agency awarded a $1,297,813 Cooperative Agreement to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). This award, with a performance period from September 1, 2023 to August 31, 2027, aims to enhance functional restoration and accelerate return to duty following lower extremity autologous free-flap harvest procedures. As a global non-profit...
The U.S. Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $1,030,660.00 Project Grant to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. to support the "LINKING SUCCESSFUL OSSEOINTEGRATION WITH SENSORIMOTOR CONTROL" research project. This 4-year grant, awarded on Sep 30, 2024 and running through Sep 29, 2028, will fund innovative medical research aimed at improving health outcomes for...
This $1,622,955 federal Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. (HJF). The grant, with a performance period from September 2024 to September 2027, will fund the development of a novel therapeutic agent called LACRIPEP to support corneal wound healing and ocular surface homeostasis. As a global nonprofit organization...
The Department of Defense's Defense Health Agency awarded a $313,151 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on February 15, 2024, supports a 2-year research project titled "AUGMENTING RET KINASE SIGNALING IN INTRINSIC NEURONAL REPAIR RESPONSES TO TREAT TRAUMATIC BRAIN INJURY". HJF, a global non-profit organization focused on...
The Department of Defense's Defense Health Agency awarded a $1,460,695 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. for the project "Development and Validation of an Epigenomic Landscape and Novel Immunotherapy in Prostate Cancer Disparities". The award period is from September 1, 2025 to August 31, 2028. The purpose of this grant is to support research...
The Department of Defense's Defense Health Agency awarded a $752,148 Cooperative Agreement on September 15, 2023 to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). The funding supports a 3-year research project investigating the maternal, fetal, and infant outcomes associated with malaria prophylactic medication exposure. The work will be performed in Westlake, MD. The Henry M. Jackson...